
Researchers have successfully used base editors to correct a genetic disease in a newborn. This treatment could save infants with a rare and deadly condition.
Original Source: https://pubmed.ncbi.nlm.nih.gov/40373211/
Researchers have successfully used base editors to correct a genetic disease in a newborn. This treatment could save infants with a rare and deadly condition.
Original Source: https://pubmed.ncbi.nlm.nih.gov/40373211/
A new study shows that the balance between STAT5 and STAT3 in dendritic cells plays a crucial role in tumor immunity and response to immunotherapy. This finding could lead to…
A phase 2b clinical trial showed that low-dose IL-2 added to riluzole is safe and effective in treating motor neurone disease. The trial was funded by several organizations including the…